Updated Jul 16, 2026
Huh Hoyoung has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $1.50M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2024-11-18 | PKBO | Peak Bio, Inc. | D — Derivative transaction | 372.9K | — | |
| 2024-11-18 | PKBO | Peak Bio, Inc. | D — Derivative transaction | 8.38M | — | |
| 2024-11-18 | PKBO | Peak Bio, Inc. | D — Derivative transaction | 4.57M | — | |
| 2024-11-18 | PKBO | Peak Bio, Inc. | J — Other acquisition / disposition | 4.57M | — |
Huh Hoyoung is a corporate insider — currently tracked as Director of PLIANT THERAPEUTICS, INC. (PLRX). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 4 open-market purchases ($1.50M) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Huh Hoyoung profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.